USFDA inspects Sun Pharma’s Halol facility in Gujarat

08 Dec 2016 Evaluate

Sun Pharmaceutical Industries’ Halol facility in Gujarat has inspected by the US Food and Drug Administration (USFDA) from November 17, 2016 to December 1, 2016. The company has been issued a Form 483, citing nine inspectional observations. None of those observations were characterized by the USFDA as repeat observations. The company is preparing its responses to the observations, which will be submitted to USFDA within 15 business days of receipt of the Form-483. The company intends to implement promptly any corrective actions and improvements that may be necessary as a result of the observations and to continue to work cooperatively with USFDA. 

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1667.25 -27.40 (-1.62%)
06-Apr-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.25
Dr. Reddys Lab 1201.50
Cipla 1176.25
Zydus Lifesciences 856.65
Lupin 2246.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×